Liberty Vision is excited to exhibit at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington D.C. from September 29th to October 2nd, 2024! If you’re attending, stop by the exhibit hall and see us at booth number 1446. Here is a link to the...
A joint article by the team at Duke Eye Center and Liberty Vision Founder Dr. Paul Finger highlights the effectiveness of the Y-90 Disc in treating squamous cell carcinoma: Read more Yttrium-90 (90Y) Brachytherapy for Squamous Carcinoma: Treatment of the Conjunctiva,...
In the 2024 copy of VISION magazine, Duke Eye Center features the Liberty Vision Y-90 Disc procedure that the center has recently started performing. Under the guidance of Dr. Miguel Materin, MD, Division Chief of Duke’s newly formed Division of Ocular Oncology,...
Liberty Vision is pleased to announce the world’s first publication on LV Y-90 Disc brachytherapy! This new technology was initially employed to treat patients with iris, and iridociliary melanomas as well as ocular surface malignant squamous carcinoma. However,...
We are excited to announce that the results from a procedure utilizing our iWand P and LV Y-90 Disc to treat choroidal melanoma will be presented as an abstract at The Retina Society 55th Annual meeting in November titled The 4-Minute Plaque: High Dose Rate (HDR)...
